Phase II feasibility study of adjuvant S-1 plus CPT-11 for stage III gastric cancer patients after curative D2 gastrectomy (OGSG 0801).

被引：0
|
作者：
Kimura, Yutaka
Fujitani, Kazumasa
Ueda, Shugo
Taniguchi, Hirokazu
Imamura, Hiroshi
Gofuku, Junji
Tamura, Shigeyuki
Kurokawa, Yukinori
Takiuchi, Hiroya
Furukawa, Hiroshi
机构：
[1] NTT West Osaka Hosp, Dept Surg, Osaka, Japan
[2] Osaka Natl Hosp, Osaka, Japan
[3] Kitano Hosp, Dept Surg, Osaka, Japan
[4] NTT West Osaka Hosp, Osaka, Japan
[5] Sakai Municipal Hosp, Sakai, Osaka, Japan
[6] Kaizuka Municipal Hosp, Dept Surg, Kaizuka, Japan
[7] Kansai Rosai Hosp, Amagasaki, Hyogo, Japan
[8] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Osaka, Japan
[9] Osaka Med Coll, Osaka, Japan
[10] Sakai Municipal Hosp, Dept Surg, Sakai, Osaka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.142
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
142
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer
    Noriyuki Hirahara
    Takeshi Matsubara
    Shunsuke Kaji
    Tetsu Yamamoto
    Ryoji Hyakudomi
    Kiyoe Takai
    Kazunari Ishitobi
    Yuki Uchida
    Yoshitsugu Tajima
    BMC Cancer, 21
  • [32] Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer
    Hirahara, Noriyuki
    Matsubara, Takeshi
    Kaji, Shunsuke
    Yamamoto, Tetsu
    Hyakudomi, Ryoji
    Takai, Kiyoe
    Ishitobi, Kazunari
    Uchida, Yuki
    Tajima, Yoshitsugu
    BMC CANCER, 2021, 21 (01)
  • [33] Phase II trial of a combination chemotherapy of CPT-11 and S-1 in patients with advanced/recurrent colorectal cancer (OGSG-0405)
    Tomita, N.
    Okamura, S.
    Nakata, K.
    Murata, K.
    Tokunaga, Y.
    Umeki, M.
    Takiuchi, H.
    Furukawa, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [34] Adjuvant nab-paclitaxel plus S-1 versus oxaliplatin plus capecitabine after curative D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase 3 open-label, randomized controlled trial
    Yu Pengfei
    Du, Yian
    Xu, Zhiyuan
    Yang, Litao
    Ying, Jieer
    Chen, Ping
    Wei, Yunhai
    Wu, Yingjie
    Yan, Zhilong
    Xu, Hongtao
    Zhang, Xiaojing
    Li, Yong
    Zheng, Zhichao
    Chen, Zhiheng
    Cheng, Xiangdong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 386 - 386
  • [35] Phase II Study of S-1 Combined with Irinotecan (CPT-11) in Patients with Advanced Colorectal Cancer
    Tsunoda, A.
    Yasuda, N.
    Nakao, K.
    Narita, K.
    Watanabe, M.
    Matsui, N.
    Kusano, M.
    ONCOLOGY, 2009, 77 (3-4) : 192 - 196
  • [36] Efficacy of S-1 or Capecitabine Plus Oxaliplatin Adjuvant Chemotherapy for Stage II or III Gastric Cancer after Curative Gastrectomy: A Systematic Review and Meta-Analysis
    Jeong, Sang-Ho
    Kim, Rock Bum
    Oh, Sung Eun
    An, Ji Yeong
    Seo, Kyung Won
    Min, Jae-Seok
    CANCERS, 2022, 14 (16)
  • [37] Effects of an Oral Elemental Nutrition Supplement in Gastric Cancer Patients with Adjuvant S-1 Chemotherapy After Gastrectomy: A Phase II Study (OGSG1108)
    Matsuyama, J.
    Imamura, H.
    Fukui, J.
    Nishikawa, K.
    Kawada, J.
    Kawase, T.
    Kurokawa, Y.
    Shimokawa, T.
    Satoh, T.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S176 - S176
  • [38] Survival Outcomes of Two Phase 2 Studies of Adjuvant Chemotherapy with S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Patients with Gastric Cancer After D2 Gastrectomy
    Yoshiaki Nakamura
    Takeharu Yamanaka
    Keisho Chin
    Haruhiko Cho
    Hitoshi Katai
    Masanori Terashima
    Kazunari Misawa
    Motohiro Hirao
    Kazuhiro Yoshida
    Eiji Oki
    Mitsuru Sasako
    Yasunori Emi
    Hideaki Bando
    Yoshiyuki Kawashima
    Tetsu Fukunaga
    Masahiro Gotoh
    Takako Ishibashi
    Kohei Shitara
    Annals of Surgical Oncology, 2019, 26 : 465 - 472
  • [39] Survival Outcomes of Two Phase 2 Studies of Adjuvant Chemotherapy with S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Patients with Gastric Cancer After D2 Gastrectomy
    Nakamura, Yoshiaki
    Yamanaka, Takeharu
    Chin, Keisho
    Cho, Haruhiko
    Katai, Hitoshi
    Terashima, Masanori
    Misawa, Kazunari
    Hirao, Motohiro
    Yoshida, Kazuhiro
    Oki, Eiji
    Sasako, Mitsuru
    Emi, Yasunori
    Bando, Hideaki
    Kawashima, Yoshiyuki
    Fukunaga, Tetsu
    Gotoh, Masahiro
    Ishibashi, Takako
    Shitara, Kohei
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (02) : 465 - 472
  • [40] Phase II study of bi-weekly CPT-11+CDDP for patients with gastric cancer refractory to S-1 (OGSG 0504 study)
    Nakae, S.
    Hirao, M.
    Kishimoto, T.
    Iijima, S.
    Ishida, H.
    Morimoto, T.
    Imano, M.
    Goto, M.
    Uedo, N.
    Fujita, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345